{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360586667883557504.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s0026-895x(25)14614-2"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0026895X25146142?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0026895X25146142?httpAccept=text/plain"}}],"dc:title":[{"@value":"Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone."}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380586667883557507","@type":"Researcher","foaf:name":[{"@value":"K J Fehske"}]},{"@id":"https://cir.nii.ac.jp/crid/1380586667883557504","@type":"Researcher","foaf:name":[{"@value":"U Schläfer"}]},{"@id":"https://cir.nii.ac.jp/crid/1380586667883557505","@type":"Researcher","foaf:name":[{"@value":"U Wollert"}]},{"@id":"https://cir.nii.ac.jp/crid/1380586667883557506","@type":"Researcher","foaf:name":[{"@value":"W E Müller"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0026895X"}],"prism:publicationName":[{"@value":"Molecular Pharmacology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1982-03","prism:volume":"21","prism:number":"2","prism:startingPage":"387","prism:endingPage":"393"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0026895X25146142?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0026895X25146142?httpAccept=text/plain"}],"createdAt":"2025-01-30","modifiedAt":"2025-01-30","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011146124003456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"In Vivo Gold Complex Catalysis within Live Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643854008192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Consideration of albumin-mediated hepatic uptake for highly protein-bound anionic drugs: Bridging the gap of hepatic uptake clearance between in vitro and in vivo"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640749310080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Albumin–drug interaction and its clinical implication"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s0026-895x(25)14614-2"},{"@type":"CROSSREF","@value":"10.1002/anie.201610273_references_DOI_1ryL7kv2uJhYkM5NUzygGl7mkWM"},{"@type":"CROSSREF","@value":"10.1016/j.pharmthera.2021.107938_references_DOI_1ryL7kv2uJhYkM5NUzygGl7mkWM"},{"@type":"CROSSREF","@value":"10.1016/j.bbagen.2013.05.005_references_DOI_1ryL7kv2uJhYkM5NUzygGl7mkWM"}]}